# Freestyle Libre-based Education on MDI in T2DM (FreEdoM-2)

Study · id `cardio:ct-nct04926623` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04926623](<https://clinicaltrials.gov/study/NCT04926623>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04926623

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 159 participants.

## Technical summary

Registry record NCT04926623. Randomized; no masking; primary purpose health services research. Start 2021-06-17 (actual); primary completion 2022-10-26 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose health services research
- Phase: Not applicable
- Enrolled: 159 participants (enrolled count; ClinicalTrials.gov record NCT04926623, source copy `cardio:ctgov-nct04926623-2024-06-14`, retrieved 2026-10-26)
- Started: 2021-06-17 (actual) (ClinicalTrials.gov record NCT04926623, source copy `cardio:ctgov-nct04926623-2024-06-14`, retrieved 2026-10-26)
- Primary completion: 2022-10-26 (actual) (ClinicalTrials.gov record NCT04926623, source copy `cardio:ctgov-nct04926623-2024-06-14`, retrieved 2026-10-26)
- Completion: 2023-04-04 (actual) (ClinicalTrials.gov record NCT04926623, source copy `cardio:ctgov-nct04926623-2024-06-14`, retrieved 2026-10-26)
- Countries: South Korea (ClinicalTrials.gov record NCT04926623, source copy `cardio:ctgov-nct04926623-2024-06-14`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04926623-2024-06-14`, retrieved 2026-10-26)

## The registry's words

- Brief title: Freestyle Libre-based Education on MDI in T2DM (FreEdoM-2)
- Condition: Type 2 Diabetes Mellitus
- Intervention (Device): FreeStyle Libre 24 weeks
- Intervention (Other): SMBG (22 weeks) and blind CGM (2 weeks)
- Lead sponsor: Daewoong Pharmaceutical Co. LTD.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as the lead sponsor: Daewoong Pharmaceutical Co. LTD. (`cardio:org-daewoong-pharmaceutical-co-ltd`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Continuous glucose monitoring with structured education in adults with type 2 diabetes managed by multiple daily insulin injections: a multicentre randomised controlled trial (`cardio:pubmed-38639876`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: e2dda8f03cdf87c3c09834a8c8bac2ea00d7a8f9100394fb67311d787f01bbe9
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
